Adjuvant therapy with zinc supplementation; anti-inflammatory and anti-oxidative role in multiple myeloma patients receiving autologous hematopoietic stem cell transplantation: a randomized controlled clinical trial.

Plain-language guide to PMID 39217594 (2024): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID: 39217594
Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine
Year: 2024
Study type: Randomized Controlled Trial
Authors: Jahankhani K et al. (8 authors)
DOI: 10.1007/s10534-024-00630-0

What This Study Did, in Plain Language

What Was Tested

This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.

Multiple myeloma (MM) patients are often accompanied by heightened levels of oxidative stress, even following bone marrow transplantation.

Trace mineral supplements have been found to regulate and inhibit the activity of oxidative radicals and inflammatory factors, which are involved in the pathogenesis of MM.

Who Took Part

The age groups tagged for this paper are adults, middle-aged adults and older adults, both men and women.

How the Study Was Run

In design terms this was a randomized and placebo-controlled study.

The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.

Furthermore, the protein level of oxidative markers in serum samples was assessed.

What Was Measured

Multiple myeloma (MM) patients are often accompanied by heightened levels of oxidative stress, even following bone marrow transplantation.

Real-time PCR was employed to measure the expression of oxidative/antioxidative genes.

The subject headings attached to it are Multiple Myeloma, Zinc, Hematopoietic Stem Cell Transplantation, Dietary Supplements, Antioxidants, Oxidative Stress and Transplantation, Autologous.

Author keywords: Autologous hematopoietic stem cell transplantation, Inflammation and Trace mineral.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.

The publication is from 2024 (Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine), a journal based in Netherlands.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Vitamin D, K2, Magnesium and Zinc in the library

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.